Chris Nolet's Insider Trades & SAST Disclosures

Chris Nolet's most recent trade in ArriVent BioPharma Inc. was a trade of 15,502 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2025.

Share

Note

This is a custom search result for pattern Chris Nolet.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
ArriVent BioPharma Inc	Christian W. Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jun 2025	15,502	15,502	-		-	Non-Qualified Stock Option (right to buy)
Revance Therapeutics Inc	Christian W. Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2024	23,458	23,458	-		-	Stock Option (Right to buy)
Revance Therapeutics Inc	Christian W. Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2024	15,000	43,606 (0%)	0%		0	Common Stock
ArriVent BioPharma Inc	Christian W. Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jan 2024	17,884	17,884	-		-	Stock Option (right to buy)
Revance Therapeutics Inc	Christian Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2023	5,915	5,915	-		-	Stock Option (Right to buy)
Revance Therapeutics Inc	Christian Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 May 2023	3,534	28,606 (0%)	0%		0	Common Stock
Revance Therapeutics Inc	Christian Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 May 2022	10,756	10,756	-		-	Stock Option (Right to buy)
Revance Therapeutics Inc	Chris Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 May 2021	7,551	7,551	-		-	Stock Option (Right to buy)
Revance Therapeutics Inc	Chris Nolet	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 May 2021	4,013	19,013 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades